By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: Correction: Mandatory notice of trade in IDEX Biometrics 22 July 2025
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > Technology > Correction: Mandatory notice of trade in IDEX Biometrics 22 July 2025
Correction: Mandatory notice of trade in IDEX Biometrics  22 July 2025
Technology

Correction: Mandatory notice of trade in IDEX Biometrics 22 July 2025

GlobeNews Wire
Last updated: 23/07/2025 3:37 PM
GlobeNews Wire
Published: 23/07/2025
Share
SHARE

July 23, 2025 05:25 ET  | Source: IDEX BIOMETRICS ASA

Reference is made to IDEX Biometrics ASA’s disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share, split in two tranches. IDEX discloses the following information on behalf of primary insiders. 

In tranche 1 of the private placement, total 4,731,594 shares :-

Pinchcliffe AS, a company closely related to CEO and CFO Anders Storbråten, subscribed to 739,360 shares, ISIN NO0013536078, at NOK 3.30 per share, and
K-konsult AS, a company closely related to chair Morten Opstad, subscribed to 128,156 shares, ISIN NO0013536078, at NOK 3.30 per share.

Contact person
Anders Storbråten, CEO and CFO
Tel: +47 4163 8582
E-mail: ir@idexbiometrics.com

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market.

For more information, visit www.idexbiometrics.com

About this notice
This correcting notice was issued by Erling Svela, Vice president of finance, on 23 July 2025 at 11:25 CET on behalf of IDEX Biometrics ASA. The information shall be disclosed according to article 19 no. 3 of the EU Market Abuse Regulation (EU 596/2014) and published in accordance with section 5‑12 of the Norwegian Securities Trading Act.

MEXC Women in Workforce Data: Leading with 43% Female Representation and 49% YoY Growth
Saudi Minister of Industry and Mineral Resources, Bandar bin Ibrahim Alkhorayef, Elected President of the 21st UNIDO General Conference
INVO Fertility Receives Notice of Allowance for Modified INVOcell Device Patent
Quanta Therapeutics Presents Positive Phase 1 Data for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, in Patients with Advanced Solid Tumors
Telescope Innovations Directors Establish Private Debt Instrumentto Accelerate Development of Self-Driving Labs
TAGGED:202581818182biometricscorrection:idexjulymandatorynewsNO0013107490noticeOslo:IDEXtrade
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
FIA: After announcing her candidacy, Laura Villars reaches out to all member clubs
News

FIA: After announcing her candidacy, Laura Villars reaches out to all member clubs

24/09/2025
Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 4.732 Million Tokens, and Total Crypto and Total Cash Holdings of $10.7 Billion
Mactores Earns AWS Healthcare Competency Status, Enabling HIPAA-Compliant AI Solutions for Improved Patient Outcomes and Operational Excellence
Hong Kong Unveils Large-Scale Toy Story 5-Themed Carnival “FOREVER TOYS @ Harbour City”
Sapu Nanos Sapu003 Advances to Human Clinical Testing – Transforming Everolimus Delivery with Full Bioavailability for Breast Cancer Patients
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?